AG
IONS icon

Algert Global’s Ionis Pharmaceuticals IONS Stock Holding History

Algert Global’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
206,853
+90,290
+77% +$6.79M 0.19% 134
2026
Q1 		$8.75M Sell
116,563
-10,642
-8% -$840K 0.13% 249
2025
Q4 		$10.1M Sell
127,205
-125,076
-50% -$9.42M 0.16% 192
2025
Q3 		$16.5M Buy
252,281
+214,191
+562% +$10.5M 0.28% 75
2025
Q2 		$1.5M Buy
+38,090
New +$1.25M 0.03% 712
2024
Q4 		– Sell
-45,430
Closed -$1.82M – 1245
2024
Q3 		$1.82M Sell
45,430
-29,920
-40% -$1.39M 0.05% 582
2024
Q2 		$3.59M Buy
75,350
+45,108
+149% +$1.85M 0.12% 270
2024
Q1 		$1.31M Buy
30,242
+12,830
+74% +$612K 0.05% 544
2023
Q4 		$881K Sell
17,412
-28,110
-62% -$1.35M 0.04% 653
2023
Q3 		$2.06M Sell
45,522
-3,730
-8% -$154K 0.1% 353
2023
Q2 		$2.02M Sell
49,252
-9,400
-16% -$361K 0.09% 381
2023
Q1 		$2.1M Sell
58,652
-14,895
-20% -$559K 0.1% 329
2022
Q4 		$2.78M Buy
73,547
+12,610
+21% +$530K 0.15% 196
2022
Q3 		$2.69M Buy
60,937
+36,037
+145% +$1.52M 0.16% 183
2022
Q2 		$922K Buy
24,900
+11,556
+87% +$436K 0.07% 519
2022
Q1 		$494K Sell
13,344
-25,086
-65% -$821K 0.03% 818
2021
Q4 		$1.17M Buy
38,430
+14,956
+64% +$471K 0.15% 230
2021
Q3 		$787K Buy
+23,474
New +$884K 0.1% 348
2015
Q4 		– Sell
-6,390
Closed -$258K – 346
2015
Q3 		$258K Buy
+6,390
New +$331K 0.14% 238

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Algert Global's IONS Position: Q2 2026 in Review

Algert Global increased its Ionis Pharmaceuticals (IONS) stake by 77% in Q2 2026, buying an estimated $6.79M and bringing the position to 206,853 shares worth $16.4M. The position accounts for 0.19% of the portfolio, ranked #134.

Algert Global first reported a position in IONS in Q3 2015 and has held it in 19 quarters since. The position peaked at $16.5M in Q3 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Algert Global held 206,853 shares of Ionis Pharmaceuticals worth $16.4M as of Q2 2026.
  • Algert Global bought 90,290 Ionis Pharmaceuticals shares in Q2 2026, an estimated $6.79M.
  • Ionis Pharmaceuticals made up 0.19% of Algert Global's portfolio in Q2 2026, its #134 holding.
  • Algert Global first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 19 quarters since.
  • Algert Global's Ionis Pharmaceuticals position peaked at $16.5M in Q3 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.